These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8855183)

  • 1. The course of galactose elimination capacity in patients with alcoholic cirrhosis: possible use as a surrogate marker for death.
    Merkel C; Marchesini G; Fabbri A; Bianco S; Bianchi G; Enzo E; Sacerdoti D; Zoli M; Gatta A
    Hepatology; 1996 Oct; 24(4):820-3. PubMed ID: 8855183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative liver function tests as surrogate markers for end-points in controlled clinical trials: a retrospective feasibility study.
    Lotterer E; Högel J; Gaus W; Fleig WE; Bircher J
    Hepatology; 1997 Dec; 26(6):1426-33. PubMed ID: 9397982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accurate prediction of death by serial determination of galactose elimination capacity in primary biliary cirrhosis: a comparison with the Mayo model.
    Reichen J; Widmer T; Cotting J
    Hepatology; 1991 Sep; 14(3):504-10. PubMed ID: 1874495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The quantitative liver function as measured by the galactose elimination capacity. II. Prognostic value and changes during disease in patients with cirrhosis.
    Lindskov J
    Acta Med Scand; 1982; 212(5):303-8. PubMed ID: 7180580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term prognosis of patients with alcoholic liver cirrhosis: a 15-year follow-up study of 100 Norwegian patients admitted to one unit.
    Bell H; Jahnsen J; Kittang E; Raknerud N; Sandvik L
    Scand J Gastroenterol; 2004 Sep; 39(9):858-63. PubMed ID: 15513384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Increased incidence of hepatocellular carcinoma in abstinent patients with alcoholic cirrhosis].
    Nishiuchi M; Shinji Y
    Gan To Kagaku Ryoho; 1990 Jan; 17(1):1-6. PubMed ID: 2153367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A shorter duration of pre-transplant abstinence predicts problem drinking after liver transplantation.
    Tandon P; Goodman KJ; Ma MM; Wong WW; Mason AL; Meeberg G; Bergsten D; Carbonneau M; Bain VG
    Am J Gastroenterol; 2009 Jul; 104(7):1700-6. PubMed ID: 19471253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgAs against acetaldehyde-modified red cell protein as a marker of ethanol consumption in male alcoholic subjects, moderate drinkers, and abstainers.
    Hietala J; Koivisto H; Latvala J; Anttila P; Niemelä O
    Alcohol Clin Exp Res; 2006 Oct; 30(10):1693-8. PubMed ID: 17010136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alcohol use after liver transplantation in alcoholics: a clinical cohort follow-up study.
    Lucey MR; Carr K; Beresford TP; Fisher LR; Shieck V; Brown KA; Campbell DA; Appelman HD
    Hepatology; 1997 May; 25(5):1223-7. PubMed ID: 9141441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The galactose breath test. Modification of the method and comparison with galactose elimination capacity and plasma disappearance of bromsulphatein (author's transl)].
    Grimm L; Bircher J; Preisig R
    Z Gastroenterol; 1980 Jan; 18(1):45-56. PubMed ID: 7385933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of hepatitis B and C virus infection on the clinical prognosis of alcoholic liver cirrhosis.
    Yamanaka T; Shiraki K; Nakazaawa S; Okano H; Ito T; Deguchi M; Takase K; Nakano T
    Anticancer Res; 2001; 21(4B):2937-40. PubMed ID: 11712790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Descriptive epidemiology of patients with alcoholic liver disease hospitalized in a hepato-gastroenterology service].
    Naveau S; Borotto E; Giraud V; Bardou M; Aubert A; Lazizi Y; Capron F; Poynard T; Chaput JC
    Gastroenterol Clin Biol; 1999 May; 23(5):544-51. PubMed ID: 10429861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validity of carbohydrate-deficient transferrin (%CDT), gamma-glutamyltransferase (gamma-GT) and mean corpuscular erythrocyte volume (MCV) as biomarkers for chronic alcohol abuse: a study in patients with alcohol dependence and liver disorders of non-alcoholic and alcoholic origin.
    Hock B; Schwarz M; Domke I; Grunert VP; Wuertemberger M; Schiemann U; Horster S; Limmer C; Stecker G; Soyka M
    Addiction; 2005 Oct; 100(10):1477-86. PubMed ID: 16185209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negative impact of de novo malignancies rather than alcohol relapse on survival after liver transplantation for alcoholic cirrhosis: a retrospective analysis of 305 patients in a single center.
    Dumortier J; Guillaud O; Adham M; Boucaud C; Delafosse B; Bouffard Y; Paliard P; Scoazec JY; Boillot O
    Am J Gastroenterol; 2007 May; 102(5):1032-41. PubMed ID: 17313502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Economic aspect of alcohol-related disabilities in patients of gastroenterology and hepatology].
    Itakura M; Nishizaki Y
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2005 Jun; 40(3):191-7. PubMed ID: 16038420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. National survey of hepatocellular carcinoma in heavy drinkers in Japan.
    Horie Y; Yamagishi Y; Kajihara M; Kato S; Ishii H
    Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):32S-36S. PubMed ID: 12960504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative versus absolute carbohydrate-deficient transferrin as a marker of alcohol consumption in patients with acute alcoholic hepatitis.
    Halm U; Tannapfel A; Mössner J; Berr F
    Alcohol Clin Exp Res; 1999 Oct; 23(10):1614-8. PubMed ID: 10549992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term survival and predictors of relapse after orthotopic liver transplantation for alcoholic liver disease.
    Pfitzmann R; Schwenzer J; Rayes N; Seehofer D; Neuhaus R; Nüssler NC
    Liver Transpl; 2007 Feb; 13(2):197-205. PubMed ID: 17205563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors of survival in complicated viral and alcoholic cirrhosis without hepatocellular carcinoma. A retrospective study.
    Spadaro A; Luigiano C; De Caro G; Morace C; Tortorella V; Bonfiglio C; Pagano N; Consolo P; Alibrandi A; Ajello A; Ferraù O; Freni MA
    Minerva Gastroenterol Dietol; 2007 Dec; 53(4):311-9. PubMed ID: 18043549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probability of liver cancer and survival in HCV-related or alcoholic-decompensated cirrhosis. A study of 377 patients.
    Solà R; Alvarez MA; Ballesté B; Montoliu S; Rivera M; Miquel M; Cirera I; Morillas RM; Coll S; Planas R
    Liver Int; 2006 Feb; 26(1):62-72. PubMed ID: 16420511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.